tetano
Editor, Senior Moderator
Travel Medicine and Infectious Disease
Available online 21 March 2013
In Press, Corrected Proof ? Note to users
Cover image
Influenza A(H1N1)pdm09 during air travel
John Neatherlina,
Elaine H. Cramera, b, d,
Christine Dubraya,
Karen J. Marienaua,
Michelle Russella,
Hong Suna,
Melissa Whaleya,
Kathy Hancocka, e,
Krista K. Duonga,
Hannah L. Kirkinga, c, f,
Christopher Schembria, b,
Jacqueline M. Katza,
Nicole J. Cohena, Corresponding author contact information, E-mail the corresponding author,
Daniel B. Fishbeina, g
a U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, NE Mailstop C-01, Atlanta, GA 30333, USA
b Global Health Sector, SRA International, 2 Corporate Blvd NE Suite 100, Atlanta, GA 30329, USA
c University of Wisconsin School of Medicine and Public Health, 750 Highland Ave Madison, Wisconsin 53792, USA
http://dx.doi.org/10.1016/j.tmaid.2013.02.004
Summary
The global spread of the influenza A(H1N1)pdm09 virus (pH1N1) associated with travelers from North America during the onset of the 2009 pandemic demonstrates the central role of international air travel in virus migration. To characterize risk factors for pH1N1 transmission during air travel, we investigated travelers and airline employees from four North American flights carrying ill travelers with confirmed pH1N1 infection. Of 392 passengers and crew identified, information was available for 290 (74%) passengers were interviewed. Overall attack rates for acute respiratory infection and influenza-like illness 1?7 days after travel were 5.2% and 2.4% respectively. Of 43 individuals that provided sera, 4 (9.3%) tested positive for pH1N1 antibodies, including 3 with serologic evidence of asymptomatic infection. Investigation of novel influenza aboard aircraft may be instructive. However, beyond the initial outbreak phase, it may compete with community-based mitigation activities, and interpretation of findings will be difficult in the context of established community transmission.
http://www.sciencedirect.com/science/article/pii/S147789391300015X
Available online 21 March 2013
In Press, Corrected Proof ? Note to users
Cover image
Influenza A(H1N1)pdm09 during air travel
John Neatherlina,
Elaine H. Cramera, b, d,
Christine Dubraya,
Karen J. Marienaua,
Michelle Russella,
Hong Suna,
Melissa Whaleya,
Kathy Hancocka, e,
Krista K. Duonga,
Hannah L. Kirkinga, c, f,
Christopher Schembria, b,
Jacqueline M. Katza,
Nicole J. Cohena, Corresponding author contact information, E-mail the corresponding author,
Daniel B. Fishbeina, g
a U.S. Centers for Disease Control and Prevention, 1600 Clifton Road, NE Mailstop C-01, Atlanta, GA 30333, USA
b Global Health Sector, SRA International, 2 Corporate Blvd NE Suite 100, Atlanta, GA 30329, USA
c University of Wisconsin School of Medicine and Public Health, 750 Highland Ave Madison, Wisconsin 53792, USA
http://dx.doi.org/10.1016/j.tmaid.2013.02.004
Summary
The global spread of the influenza A(H1N1)pdm09 virus (pH1N1) associated with travelers from North America during the onset of the 2009 pandemic demonstrates the central role of international air travel in virus migration. To characterize risk factors for pH1N1 transmission during air travel, we investigated travelers and airline employees from four North American flights carrying ill travelers with confirmed pH1N1 infection. Of 392 passengers and crew identified, information was available for 290 (74%) passengers were interviewed. Overall attack rates for acute respiratory infection and influenza-like illness 1?7 days after travel were 5.2% and 2.4% respectively. Of 43 individuals that provided sera, 4 (9.3%) tested positive for pH1N1 antibodies, including 3 with serologic evidence of asymptomatic infection. Investigation of novel influenza aboard aircraft may be instructive. However, beyond the initial outbreak phase, it may compete with community-based mitigation activities, and interpretation of findings will be difficult in the context of established community transmission.
http://www.sciencedirect.com/science/article/pii/S147789391300015X